RUNX2 and familial pancreatic carcinoma: Runx2 is over-expressed in PDAC [17], and other factors downstream of runx2, such as osteopontin [35] and SPARC [36], are also over-expressed in PDAC and have the potential to increase pancreatic cancer invasion and metastasis [37,38].